AFP and neoplasm: The RETREAT score—comprising AFP at LT, MVI, and viable tumour burden—should be used to stratify 5-year recurrence risk (from less than 3% at score 0 to more than 75% at score ≥ 5) and to determine imaging and AFP surveillance cadence.